For a range of hospitalized patients at risk of worsening heart failure (HF), tying medical interventions to cardiac ...

Iota Biosciences, a subsidiary of Astellas Pharma, announced that it received FDA investigational device exemption (IDE) for ...

Implant grade silicones, while inherently biocompatible, are rigorously tested and scrutinized to last many years within the ...

The global cardiac assist devices market is experiencing significant growth, poised to surpass USD 1.37 billion by 2023. With a remarkable compound annual growth rate (CAGR) of 6.1% projected through ...

The US Advanced Research Projects Agency for Health is funding a six-year effort to accelerate the development of implantable ...

In the next in our Masterclass series, GP cardiologists Dr Christine A’Court and Dr Charles Gardiner explain the latest ...

A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based ...

India Pacemaker Market is flourishing due to the rising prevalence of cardiovascular diseases, growing geriatric population, increasing life expectancy, and government’s supportive reimbursement ...

A ventricular assist device (VAD) is a temporary or long-term therapy for heart failure. Learn about different types of ...

wearable devices, and AI, in early detection and personalized care. Over the past two decades, India has witnessed a ...